Acute Kidney Injury May Follow BRAF Inhibitor TreatmentAcute Kidney Injury May Follow BRAF Inhibitor Treatment

Several cases of acute kidney injury (AKI) have occurred in patients whose metastatic melanoma was treated with the BRAF inhibitors vemurafenib and dabrafenib, according to findings from the Food and Drug Administration Adverse Event Reporting System (FAERS). Reuters Health Information
Source: Medscape Nephrology Headlines - Category: Urology & Nephrology Tags: Nephrology News Source Type: news